• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER CRIBRIFORM OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER CRIBRIFORM OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-MF-025
Device Problem Material Deformation (2976)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/26/2020
Event Type  malfunction  
Manufacturer Narrative
Further information regarding this event has been requested.Investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2020 a 25 mm amplatzer cribriform occluder was chosen for a pfo closure procedure.While the implanting physician was attempting the closure, the physician called abbott rep, as the abbott rep was not notified prior.Although the device was not released the abbott rep was called via (b)(6) after its deployment to help ascertain the cause of the left atrial disc becoming misshaped.The physician explained the events as they occurred during before and during deployment.The abbott rep stated that it was difficult to ascertain the cause remotely after device deployment.Based on limited information available, the abbott rep suggested the recapture and retrieval of the 25mm device.The device was recaptured and retrieved without issue.After retrieving the device, the physician examined if device was in fact deformed.The physician confirmed that the left atrial disc was not returning to its proper shape.A new device was recommended, and physician chose to upsize to a 30mm cribiform device, the same deformation occurred.It was at this time the physician chose to remove the device and abort the procedure.The patient remained stable throughout the procedure per the physician.Physician stated that the patient was not impacted.Devices: 25mm cribiform occluder: ref: 9-asd-mf-025, lot 6840860.30mm cribiform occluder: ref: 9-asd-mf-030, lot: 553314.
 
Manufacturer Narrative
Correction: b5 additional information: d10,g4,h2,h3,h6,h10.The reported event of a deformed, bulbous deployment was confirmed.Following the simulated deployment, the bulbous shape returned to normal and met functional specifications when analyzed at abbott.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all defined manufacturing specifications.A capa was initiated for further investigation and did not identify a product quality issue.However, corrective actions to further enhance performance are being pursued per internal operating procedures.
 
Event Description
On (b)(6) 2020 a 25 mm amplatzer cribriform occluder was chosen for a pfo closure procedure.While the implanting physican was attempting the closure, the physician called abbott rep, as the abbott rep was not notified prior.Although the device was not released the abbott rep was called via facetime after its deployment to help ascertain the cause of the left atrial disc becoming mishaped.The physician explained the events as they occurred during before and during deployment.The abbott rep stated that it was difficult to ascertain the cause remotely after device deployment.Based on limited information available, the abbott rep suggested the recapture and retrieval of the 25mm device.The device was recaptured and retireved without issue.After retrieving the device, the physician examined if device was in fact deformed.The physician confirmed that the left atrial disc was not returning to its proper shape.A new device was recommended, after attempting with 25mm x2, the physician chose to upsize to a 30mm cribiform device, the same deformation occurred.It was at this time the physician chose to remove the device and abort the procedure.The patient remained stable throughout the procedure per the physician.Physician stated that the patient was not impacted.Devices: 25mm cribiform occluder ref: 9-asd-mf-025 lot 6840860; 9-asd-mf-025 lot: 6928439, 30mm cribiform occluder ref: 9-asd-mf-030 lot: 553314.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER CRIBRIFORM OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10270967
MDR Text Key199824312
Report Number2135147-2020-00305
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806010298
UDI-Public00811806010298
Combination Product (y/n)N
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Other
Type of Report Initial,Followup
Report Date 08/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/14/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2024
Device Model Number9-ASD-MF-025
Device Catalogue Number9-ASD-MF-025
Device Lot Number6840860
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-